CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy. - Bai X; Guo ZQ; Zhang YP; Fan ZZ; Liu LJ; Liu L; Long LL; Ma SC; Wang J; Fang Y; Tang XR; Zeng YJ; et al. (Nature communications, 2023)